TXG earnings
10x Genomics (TXG) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- TXG reports next on Feb 11, 2027, with EPS of -0.20 expected.
- TXG beat EPS estimates in 10 of its last 17 reports.
TXG earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 5, 2026 | -0.15 | -0.27 | 43.82% | $150.67M |
| Q2 2026 | Aug 6, 2026 | -0.14 | -0.24 | 42.41% | $151.04M |
| Q1 2026 | May 7, 2026 | -0.10 | -0.29 | 65.52% | $150.84M |
| Q4 2025 | Feb 12, 2026 | -0.13 | -0.19 | 31.58% | $166.03M |
| Q3 2025 | Nov 6, 2025 | -0.22 | -0.07 | -214.29% | $149.00M |
| Q2 2025 | Aug 7, 2025 | 0.28 | -0.35 | 180.00% | $172.91M |
| Q1 2025 | May 8, 2025 | -0.36 | -0.45 | 20.00% | $154.88M |
| Q4 2024 | Feb 12, 2025 | -0.40 | -0.29 | -37.93% | $165.02M |
| Q3 2024 | Oct 29, 2024 | -0.30 | -0.34 | 11.76% | $151.65M |
| Q2 2024 | Aug 8, 2024 | -0.32 | -0.47 | 31.91% | $153.10M |
| Q1 2024 | Apr 30, 2024 | -0.50 | -0.46 | -8.70% | $141.01M |
| Q4 2023 | Feb 15, 2024 | -0.41 | -0.36 | -13.89% | $183.98M |
| Q3 2023 | Nov 2, 2023 | -0.51 | -0.45 | -13.33% | $153.64M |
| Q2 2023 | Aug 3, 2023 | -0.53 | -0.39 | -35.90% | $146.82M |
| Q1 2023 | May 3, 2023 | -0.44 | -0.38 | -15.79% | $134.28M |
| Q4 2022 | Feb 15, 2023 | -0.15 | -0.29 | 48.28% | $156.23M |
| Q3 2022 | Nov 2, 2022 | -0.37 | -0.45 | 17.78% | $131.07M |